Notable Alums
Specialty: Endocrinology
Graduation Year: 1969
Paul Jellinger
Paul Jellinger, M.D. ’69, MACE, is professor of Clinical Medicine on the Voluntary Faculty at the University of Miami Miller School of Medicine. He is in clinical practice at the Center for Diabetes and Endocrine Care in Hollywood, Florida.
Dr. Jellinger served as past president of the American Association of Clinical Endocrinologists (AACE) and the American College of Endocrinology (ACE). Dr. Jellinger is a Master of the American College of Endocrinology (MACE), one of only 50+ endocrinologists to earn that distinction to date. In 2017, he received the Distinguished Service Award from the American College of Endocrinology.
After graduating from the Wayne State University School of Medicine, he competed residencies at Beth Israel Hospital and Mount Sinai Hospital in New York. He then completed a National Institutes of Health fellowship in Endocrinology at Mount Sinai Hospital.
Dr. Jellinger, a founding steering committee member of AACE, was active on that organization’s board of directors for more than 20 years, serving as chair of a number of its committees. He also served as a Task Force member of numerous AACE committees that developed the association’s “Guidelines for the Management of Diabetes Mellitus,” “The Evaluation and Treatment of Hyperthyroidism and Hypothyroidism” and participated in numerous published Consensus Conferences related to diabetes and insulin resistance.
He co-authored and chaired the first published “ACE/AACE Roadmap for the Prevention and Treatment of Type 2 Diabetes” and was a contributing author to the “AACE/ACE Guidelines for the Treatment of Diabetes Mellitus”. Dr. Jellinger co-chaired the 2009 Task Force that published the first “AACE/ACE Diabetes Algorithm for Glycemic Control” and has been a Task Force member yearly. He served as chair of the published 2017 “AACE/ACE Guidelines for the Management of Dyslipidemia and Prevention of Cardiovascular Disease” and co-chaired the recently completed “AACE/ACE Lipid Disorders Treatment Algorithm.”
Dr. Jellinger served as past president of the American Association of Clinical Endocrinologists (AACE) and the American College of Endocrinology (ACE). Dr. Jellinger is a Master of the American College of Endocrinology (MACE), one of only 50+ endocrinologists to earn that distinction to date. In 2017, he received the Distinguished Service Award from the American College of Endocrinology.
After graduating from the Wayne State University School of Medicine, he competed residencies at Beth Israel Hospital and Mount Sinai Hospital in New York. He then completed a National Institutes of Health fellowship in Endocrinology at Mount Sinai Hospital.
Dr. Jellinger, a founding steering committee member of AACE, was active on that organization’s board of directors for more than 20 years, serving as chair of a number of its committees. He also served as a Task Force member of numerous AACE committees that developed the association’s “Guidelines for the Management of Diabetes Mellitus,” “The Evaluation and Treatment of Hyperthyroidism and Hypothyroidism” and participated in numerous published Consensus Conferences related to diabetes and insulin resistance.
He co-authored and chaired the first published “ACE/AACE Roadmap for the Prevention and Treatment of Type 2 Diabetes” and was a contributing author to the “AACE/ACE Guidelines for the Treatment of Diabetes Mellitus”. Dr. Jellinger co-chaired the 2009 Task Force that published the first “AACE/ACE Diabetes Algorithm for Glycemic Control” and has been a Task Force member yearly. He served as chair of the published 2017 “AACE/ACE Guidelines for the Management of Dyslipidemia and Prevention of Cardiovascular Disease” and co-chaired the recently completed “AACE/ACE Lipid Disorders Treatment Algorithm.”